Back to results

TerminatedPhase 2

A Study of Lerociclib in Participants With Advanced Breast Cancer

NCT05085002

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Cancer Specialists of North Florida

Jacksonville, Florida, United States

+20 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2021-12-21
Enrollment: 100 participants
Sponsor: EQRx, Inc.
Purpose: treatment

Locations (21)

Cancer Specialists of North FloridaJacksonville, Florida, United States
Nebraska Cancer SpecialistsOmaha, Nebraska, United States
Oregon Oncology SpecialistsSalem, Oregon, United States
Cancer Care Associates of York, Inc.York, Pennsylvania, United States
Tranquil Clinical ResearchWebster, Texas, United States
Northwest Medical Specialties PLLCTacoma, Washington, United States
UZAEdegem, Belgium
Ziekenhuizen K.U.Leuven, Campus gasthuisbergLeuven, Belgium
CHA LibramontLibramont, Belgium
Clinique Saint-Pierre asblOttignies, Belgium
vzw Verenigde Ziekenhuizen van Waas en Durme - VITAZSint-Niklaas, Belgium
LTD "Brothers"Batumi, Georgia
ARENSIA Exploratory Medicine LLCTbilisi, Georgia
Ltd Israeli-Georgian Medical Research Clinic HelsicoreTbilisi, Georgia
LTD "Health House"Tbilisi, Georgia
Ltd "Multiprofile Clinic Consilium Medulla "Tbilisi, Georgia
Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori"Meldola, Italy
PanAmerican Clinical Research GuadalajaraGuadalajara, Jalisco, Mexico
PanAmerican Clinical Research CuernavacaCuernavaca, Mexico
PanAmerican Clinical Research, QueretaroQuerétaro, Mexico
IMSP Institutul Oncologic, Arsenia Exploratory MedicineChisinau, Moldova

A Study of Lerociclib in Participants With Advanced Breast Cancer — TrialFind